权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Integrating Addiction Research in Health Systems: The Addiction Research Network

将成瘾研究纳入卫生系统：成瘾研究网络

基本信息

批准号：
9471734
负责人：
KATHARINE ANTHONY BRADLEY
金额：
$ 200.29万
依托单位：
KAISER FOUNDATION RESEARCH INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-09-01 至 2020-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9471734
关键词：
Accident and Emergency department Address Adolescent Adult Age Alcohol or Other Drugs use Behavior Therapy Biometry Calibration Cancer Research Network Caring Childhood Chronic Disease Clinical Clinical Trials Network Comorbidity Data Development Diabetes Mellitus Economics Electronic Health Record Ensure Family Policy Foundations Future Geography Goals Health Health Care Reform Health Services Research Health system Healthcare Healthcare Systems Hypertension Influentials International Lead Learning Measures Medical Mental Health Minority Monitor Operative Surgical Procedures Outcome Outcomes Research Patient Monitoring Patient-Centered Care Patient-Focused Outcomes Patients Pharmaceutical Preparations Policies Population Population Study Pragmatic clinical trial Primary Health Care Privatization Public Health Quality of Care Randomized Controlled Trials Reporting Research Research Design Research Infrastructure Research Methodology Research Personnel Services Severities Substance Use Disorder System Testing Time United States United States National Institutes of Health Variant Vision Work Youth addiction alcohol misuse clinical care comparative effectiveness design eHealth effective intervention effective therapy effectiveness research ethnic diversity evidence base experience health care delivery implementation research improved improved outcome innovation learning network medical specialties opioid misuse patient oriented patient registry population based pragmatic trial programs public health relevance racial and ethnic screening social stigma study population virtual young adult

项目摘要

DESCRIPTION: Over 20 million US adults and youth suffer from substance use disorders (SUDs) and substance use (SU) related problems. However, most people with SUDs never receive SUD treatment. Historically, research on SUDs has focused on the small minority of patients with SUDs who are seeking, or already engaged in, specialty SUD treatment. The overall goal of the proposed Addictions Research Network (ARN) node of the Clinical Trials Network will be to conduct cutting edge research to improve outcomes in all patients with SU/SUD who are seen in medical settings. The ARN includes 15 large health systems across the US that use the HMO Research Network's (HMORN's) Virtual Data Warehouse, providing geographic and racial/ethnic diversity as well as variation in systems of medical and SU/SUD care. The proposed ARN node has 3 broad agendas-1) to evaluate effective practices for identifying, engaging and treating patients with SU or SUDs in medical settings; 2) to develop and test effective, practical ways to implement these practices in a sustained manner as part of routine medical care; and 3) to develop and disseminate innovative research methods on SU and SUDs. Three PIs will lead the ARN node, each with expertise critical to our research agenda. Dr. Weisner, who has more than 25 years of experience leading SUD research in public and private medical settings, will lead the ARN as Senior PI at Kaiser Permanente. She partners at Kaiser Permanente with Dr. Campbell, an expert in research on opioid misuse and patient-centered and comparative effectiveness research, and Dr. Bradley, Senior PI at Group Health, who has 20 years of research experience targeting non-treatment-seeking patients with alcohol misuse and SUDs in medical settings. The ARN will have 3 Cores: 1) an Administrative Core will support all aspects of the ARN node; 2) an Implementation Core will support patient-centered design of practical, sustainable approaches to implementing SUD care in routine medical settings using electronic health records (EHRs), and; 3) an Analytics Core with expertise in programming, biostatistics using EHR data, and economics, will support innovative methods research and study design. ARN work will leverage the HMORN's 20 years of conducting pragmatic clinical trials and comparative effectiveness research across health systems using EHRs and the nationwide Virtual Data Warehouse. The ARN node will provide a robust foundation for population-based studies-including pragmatic randomized controlled trials, comparative effectiveness studies, and implementation research-that can evaluate long-term health outcomes. Moreover, through our connection to 15 learning healthcare systems, our research will design approaches to improve the quality of care for SU and SUDs in real-world medical settings. In this way-with the other CTN nodes-the ARN node will help build the infrastructure required for the next era of addictions health services research.